Design Therapeutics, Inc. Earnings Per Share (Basic)
Design Therapeutics, Inc. (DSGN) reported Earnings Per Share (Basic) of -$0.32 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-03
- Design Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.32.
- Design Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.29.
- Design Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.27.
- Design Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.30.
- Design Therapeutics, Inc. earnings per share, basic for fiscal 2025 was -$1.22.
- Design Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$0.88.
- Design Therapeutics, Inc. earnings per share, basic for fiscal 2023 was -$1.19.
- Design Therapeutics, Inc. earnings per share, basic for fiscal 2022 was -$1.14.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.32 10-Q · filed 2026-08-03 | -$0.61 10-Q · filed 2026-08-03 | -$0.88 derived: net income ÷ weighted average shares · filed 2026-08-03 | -$1.18 derived: net income ÷ weighted average shares · filed 2026-08-03 |
| 2026-03-31 | -$0.29 10-Q · filed 2026-04-28 | -$0.56 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$0.86 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$1.19 derived: net income ÷ weighted average shares · filed 2026-08-03 |
| 2025-12-31 | -$0.27 derived: net income ÷ weighted average shares · filed 2026-03-09 | -$0.57 derived: net income ÷ weighted average shares · filed 2026-03-09 | -$0.91 derived: net income ÷ weighted average shares · filed 2026-08-03 | -$1.22 10-K · filed 2026-03-09 |
| 2025-09-30 | -$0.30 10-Q · filed 2025-11-05 | -$0.63 derived: net income ÷ weighted average shares · filed 2026-08-03 | -$0.95 10-Q · filed 2025-11-05 | -$1.19 derived: net income ÷ weighted average shares · filed 2026-08-03 |
| 2025-06-30 | -$0.34 10-Q · filed 2026-08-03 | -$0.65 10-Q · filed 2026-08-03 | -$0.89 derived: net income ÷ weighted average shares · filed 2026-08-03 | -$1.12 derived: net income ÷ weighted average shares · filed 2026-08-03 |
| 2025-03-31 | -$0.31 10-Q · filed 2026-04-28 | -$0.55 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$0.78 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$0.99 derived: net income ÷ weighted average shares · filed 2026-04-28 |
| 2024-12-31 | -$0.24 derived: net income ÷ weighted average shares · filed 2026-03-09 | -$0.47 derived: net income ÷ weighted average shares · filed 2026-03-09 | -$0.68 derived: net income ÷ weighted average shares · filed 2026-03-09 | -$0.88 10-K · filed 2026-03-09 |
| 2024-09-30 | -$0.23 10-Q · filed 2025-11-05 | -$0.44 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$0.64 10-Q · filed 2025-11-05 | -$0.85 derived: net income ÷ weighted average shares · filed 2025-11-05 |
| 2024-06-30 | -$0.21 10-Q · filed 2025-08-07 | -$0.41 10-Q · filed 2025-08-07 | -$0.62 derived: net income ÷ weighted average shares · filed 2025-08-07 | -$0.90 derived: net income ÷ weighted average shares · filed 2025-08-07 |
| 2024-03-31 | -$0.20 10-Q · filed 2025-05-07 | -$0.41 derived: net income ÷ weighted average shares · filed 2025-05-07 | -$0.69 derived: net income ÷ weighted average shares · filed 2025-05-07 | -$1.05 derived: net income ÷ weighted average shares · filed 2025-05-07 |
| 2023-12-31 | -$0.21 derived: net income ÷ weighted average shares · filed 2025-03-10 | -$0.49 derived: net income ÷ weighted average shares · filed 2025-03-10 | -$0.85 derived: net income ÷ weighted average shares · filed 2025-03-10 | -$1.19 10-K · filed 2025-03-10 |
| 2023-09-30 | -$0.28 10-Q · filed 2024-11-07 | -$0.64 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$0.98 10-Q · filed 2024-11-07 | -$1.29 derived: net income ÷ weighted average shares · filed 2024-11-07 |
| 2023-06-30 | -$0.36 10-Q · filed 2024-08-05 | -$0.70 10-Q · filed 2024-08-05 | -$1.01 derived: net income ÷ weighted average shares · filed 2024-08-05 | -$1.33 derived: net income ÷ weighted average shares · filed 2024-08-05 |
| 2023-03-31 | -$0.35 10-Q · filed 2024-05-08 | -$0.66 derived: net income ÷ weighted average shares · filed 2024-05-08 | -$0.97 derived: net income ÷ weighted average shares · filed 2024-05-08 | -$1.24 derived: net income ÷ weighted average shares · filed 2024-05-08 |
| 2022-12-31 | -$0.31 derived: net income ÷ weighted average shares · filed 2024-03-19 | -$0.63 derived: net income ÷ weighted average shares · filed 2024-03-19 | -$0.90 derived: net income ÷ weighted average shares · filed 2024-03-19 | -$1.14 10-K · filed 2024-03-19 |
| 2022-09-30 | -$0.32 10-Q · filed 2023-11-13 | -$0.59 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$0.83 10-Q · filed 2023-11-13 | -$1.03 derived: net income ÷ weighted average shares · filed 2023-11-13 |
| 2022-06-30 | -$0.27 10-Q · filed 2023-08-14 | -$0.51 10-Q · filed 2023-08-14 | -$0.71 derived: net income ÷ weighted average shares · filed 2023-08-14 | -$0.91 derived: net income ÷ weighted average shares · filed 2023-08-14 |
| 2022-03-31 | -$0.24 10-Q · filed 2023-05-09 | -$0.44 derived: net income ÷ weighted average shares · filed 2023-05-09 | -$0.64 derived: net income ÷ weighted average shares · filed 2023-05-09 | -$0.78 derived: net income ÷ weighted average shares · filed 2023-05-09 |
| 2021-12-31 | -$0.20 derived: net income ÷ weighted average shares · filed 2023-03-14 | -$0.40 derived: net income ÷ weighted average shares · filed 2023-03-14 | -$0.54 derived: net income ÷ weighted average shares · filed 2023-03-14 | -$0.77 10-K · filed 2023-03-14 |
| 2021-09-30 | -$0.21 10-Q · filed 2022-11-03 | -$0.34 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$0.57 10-Q · filed 2022-11-03 | |
| 2021-06-30 | -$0.14 10-Q · filed 2022-08-08 | -$0.36 10-Q · filed 2022-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |